PharmacoEconomics

Cost Effectiveness of Leukotriene Modifiers in Adults with Asthma
pp. 727-742(16)
Author: Heaton, Pamela C.

Prostaglandin Analogues for the Treatment of Glaucoma and Ocular Hypertension: A Systematic Review of Economic Evidence
pp. 743-750(8)
Authors: Orme, Michelle; Boler, Annabel

A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials
pp. 751-765(15)
Authors: Clayson, Darren J.; Wild, Diane J.; Quarterman, Paul; Duprat-Lomon, Isabelle; Kubin, Maria; Stephen Joel Coons,

Pharmacoeconomic Analyses of Azathioprine, Methotrexate and Prospective Pharmacogenetic Testing for the Management of Inflammatory Bowel Disease
pp. 767-781(15)
Authors: Priest, Virginia L.; Begg, Evan J.; Gardiner, Sharon J.; Frampton, Christopher M.A.; Gearry, Richard B.; Barclay, Murray L.; Clark, David W.J.; Hansen, Paul

A Multi-Country Health Economic Evaluation of Highly Concentrated N-3 Polyunsaturated Fatty Acids in Secondary Prevention after Myocardial Infarction
pp. 783-795(13)
Authors: Lamotte, Mark; Annemans, Lieven; Kawalec, Pawel; Zoellner, York

Costs of Inflammatory Bowel Disease in Germany
pp. 797-814(18)
Authors: Stark, Renee; König, Hans-Helmut; Leidl, Reiner

Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada
pp. 815-830(16)
Authors: Kohli, Michele; Attard, Cheryl; Lam, Annette; Huse, Daniel; Cook, John; Bourgault, Chantal; Alemao, Evo; Yin, Donald; Marentette, Michael

National-Level Purchasing of Expensive Drugs is Increasing Pressure on the Hospital Drug Budget
pp. 831-832(2)
Authors: Jankovic, Slobodan M.; Milivojevic, Nebojsa